
Evol Science uses AI and biology to tackle cancer cell drug resistance. It combines a proteo-genomic system with an AI-driven data analytics platform to identify and target both acquired and intrinsic resistance in cancer cells. The company operates as a biotech startup focused on drug resistance, developing a pipeline for BioPharma partners and licensing IP. By enabling faster drug development and clinical translation, Evol Science aims to broaden patient access to effective therapies.

Evol Science uses AI and biology to tackle cancer cell drug resistance. It combines a proteo-genomic system with an AI-driven data analytics platform to identify and target both acquired and intrinsic resistance in cancer cells. The company operates as a biotech startup focused on drug resistance, developing a pipeline for BioPharma partners and licensing IP. By enabling faster drug development and clinical translation, Evol Science aims to broaden patient access to effective therapies.